![Alemtuzumab for multiple sclerosis: the new concept of immunomodulation | Multiple Sclerosis and Demyelinating Disorders | Full Text Alemtuzumab for multiple sclerosis: the new concept of immunomodulation | Multiple Sclerosis and Demyelinating Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40893-017-0024-4/MediaObjects/40893_2017_24_Fig2_HTML.gif)
Alemtuzumab for multiple sclerosis: the new concept of immunomodulation | Multiple Sclerosis and Demyelinating Disorders | Full Text
![Toxins | Free Full-Text | Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects | HTML Toxins | Free Full-Text | Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects | HTML](https://www.mdpi.com/toxins/toxins-06-00869/article_deploy/html/images/toxins-06-00869-g001.png)
Toxins | Free Full-Text | Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects | HTML
![1 Campath ® (alemtuzumab) Millennium & ILEX Partners, LP Oncologic Drugs Advisory Committee December 14, ppt download 1 Campath ® (alemtuzumab) Millennium & ILEX Partners, LP Oncologic Drugs Advisory Committee December 14, ppt download](https://images.slideplayer.com/25/8167448/slides/slide_6.jpg)
1 Campath ® (alemtuzumab) Millennium & ILEX Partners, LP Oncologic Drugs Advisory Committee December 14, ppt download
![Biomedicines | Free Full-Text | Monoclonal Antibodies in Multiple Sclerosis: Present and Future | HTML Biomedicines | Free Full-Text | Monoclonal Antibodies in Multiple Sclerosis: Present and Future | HTML](https://www.mdpi.com/biomedicines/biomedicines-07-00020/article_deploy/html/images/biomedicines-07-00020-g002.png)
Biomedicines | Free Full-Text | Monoclonal Antibodies in Multiple Sclerosis: Present and Future | HTML
![Mitigating alemtuzumab-associated autoimmunity in MS | Neurology Neuroimmunology & Neuroinflammation Mitigating alemtuzumab-associated autoimmunity in MS | Neurology Neuroimmunology & Neuroinflammation](https://nn.neurology.org/content/nnn/7/6/e868/F1.large.jpg)
Mitigating alemtuzumab-associated autoimmunity in MS | Neurology Neuroimmunology & Neuroinflammation
![Alemtuzumab for multiple sclerosis: the new concept of immunomodulation | Multiple Sclerosis and Demyelinating Disorders | Full Text Alemtuzumab for multiple sclerosis: the new concept of immunomodulation | Multiple Sclerosis and Demyelinating Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40893-017-0024-4/MediaObjects/40893_2017_24_Fig3_HTML.gif)
Alemtuzumab for multiple sclerosis: the new concept of immunomodulation | Multiple Sclerosis and Demyelinating Disorders | Full Text
![Frontiers | New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions | Immunology Frontiers | New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions | Immunology](https://www.frontiersin.org/files/Articles/578314/fimmu-11-578314-HTML-r1/image_m/fimmu-11-578314-g001.jpg)
Frontiers | New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions | Immunology
Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated Cytolysis
![Alemtuzumab scFv fragments and CD52 interaction study through molecular dynamics simulation and binding free energy - ScienceDirect Alemtuzumab scFv fragments and CD52 interaction study through molecular dynamics simulation and binding free energy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1093326321001200-ga1.jpg)
Alemtuzumab scFv fragments and CD52 interaction study through molecular dynamics simulation and binding free energy - ScienceDirect
![Proposed mechanism of action of alemtuzumab. a Alemtuzumab targets B... | Download Scientific Diagram Proposed mechanism of action of alemtuzumab. a Alemtuzumab targets B... | Download Scientific Diagram](https://www.researchgate.net/publication/305801587/figure/fig1/AS:962681167151122@1606532484936/Proposed-mechanism-of-action-of-alemtuzumab-a-Alemtuzumab-targets-B-and-T-lymphocytes-by_Q640.jpg)
Proposed mechanism of action of alemtuzumab. a Alemtuzumab targets B... | Download Scientific Diagram
![Mechanism of action of alemtuzumab. (a) Cellular targets of alemtuzumab... | Download Scientific Diagram Mechanism of action of alemtuzumab. (a) Cellular targets of alemtuzumab... | Download Scientific Diagram](https://www.researchgate.net/profile/Hans-Peter-Hartung-3/publication/267744221/figure/fig2/AS:392113310191622@1470498506427/Mechanism-of-action-of-alemtuzumab-a-Cellular-targets-of-alemtuzumab-during-the.png)
Mechanism of action of alemtuzumab. (a) Cellular targets of alemtuzumab... | Download Scientific Diagram
![A changing treatment landscape for multiple sclerosis: challenges and opportunities - Piehl - 2014 - Journal of Internal Medicine - Wiley Online Library A changing treatment landscape for multiple sclerosis: challenges and opportunities - Piehl - 2014 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a56796b4-8a1d-4308-aaae-b81f27f4542a/joim12204-fig-0002-m.jpg)
A changing treatment landscape for multiple sclerosis: challenges and opportunities - Piehl - 2014 - Journal of Internal Medicine - Wiley Online Library
![SciELO - Brasil - New immunosuppressive agents in pediatric transplantation New immunosuppressive agents in pediatric transplantation SciELO - Brasil - New immunosuppressive agents in pediatric transplantation New immunosuppressive agents in pediatric transplantation](https://minio.scielo.br/documentstore/1980-5322/VLd7J9TKYdmMtfSWtzjs5nh/166ee5c51d3055eed4ed0c47bdc2ccf0600caa59.jpg)